St. Louis cancer drug startup hires exec with experience taking firms public

St. Louis Business Journal

Jan 4, 2024

St. Louis-based clinical-stage biotechnology startup Wugen, which has raised more than $200 million in venture funding as it develops cancer-fighting drugs, has added to its C-suit…